481 related articles for article (PubMed ID: 19840853)
21. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.
Puhl DL; D'Amato AR; Gilbert RJ
Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859
[TBL] [Abstract][Full Text] [Related]
22. Towards a neuroprotective gene therapy for Parkinson's disease: use of adenovirus, AAV and lentivirus vectors for gene transfer of GDNF to the nigrostriatal system in the rat Parkinson model.
Björklund A; Kirik D; Rosenblad C; Georgievska B; Lundberg C; Mandel RJ
Brain Res; 2000 Dec; 886(1-2):82-98. PubMed ID: 11119690
[TBL] [Abstract][Full Text] [Related]
23. Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating "clinical proof-of-concept" for AAV-neurturin (CERE-120) in Parkinson's disease.
Bartus RT; Baumann TL; Brown L; Kruegel BR; Ostrove JM; Herzog CD
Neurobiol Aging; 2013 Jan; 34(1):35-61. PubMed ID: 22926166
[TBL] [Abstract][Full Text] [Related]
24. Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases.
Mufson EJ; Kroin JS; Sendera TJ; Sobreviela T
Prog Neurobiol; 1999 Feb; 57(4):451-84. PubMed ID: 10080385
[TBL] [Abstract][Full Text] [Related]
25. Exploring the Role of Gene Therapy for Neurological Disorders.
Puranik N; Yadav D; Chauhan PS; Kwak M; Jin JO
Curr Gene Ther; 2021; 21(1):11-22. PubMed ID: 32940177
[TBL] [Abstract][Full Text] [Related]
26. Gene transfer mediated by stem cell grafts to treat CNS injury.
Hwang DH; Jeong SR; Kim BG
Expert Opin Biol Ther; 2011 Dec; 11(12):1599-610. PubMed ID: 22017608
[TBL] [Abstract][Full Text] [Related]
27. Prospects of Neurotrophic Factors for Parkinson's Disease: Comparison of Protein and Gene Therapy.
Domanskyi A; Saarma M; Airavaara M
Hum Gene Ther; 2015 Aug; 26(8):550-9. PubMed ID: 26176331
[TBL] [Abstract][Full Text] [Related]
28. Perinatal gene delivery to the CNS.
Rahim AA; Buckley SM; Chan JK; Peebles DM; Waddington SN
Ther Deliv; 2011 Apr; 2(4):483-91. PubMed ID: 22826856
[TBL] [Abstract][Full Text] [Related]
29. Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks.
McMenamin MM; Wood MJ
Gene Ther; 2010 Apr; 17(4):448-58. PubMed ID: 20147982
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
Azzouz M; Ralph S; Wong LF; Day D; Askham Z; Barber RD; Mitrophanous KA; Kingsman SM; Mazarakis ND
Neuroreport; 2004 Apr; 15(6):985-90. PubMed ID: 15076720
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of combined viral transduction and CRISPR/Cas9 gene editing in treating neurodegenerative diseases.
Kuruvilla J; Sasmita AO; Ling APK
Neurol Sci; 2018 Nov; 39(11):1827-1835. PubMed ID: 30076486
[TBL] [Abstract][Full Text] [Related]
32. Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future.
Piguet F; Alves S; Cartier N
Hum Gene Ther; 2017 Nov; 28(11):988-1003. PubMed ID: 29035118
[TBL] [Abstract][Full Text] [Related]
33. Viral vectors for gene therapy in Parkinson's disease.
Latchman DS; Coffin RS
Rev Neurosci; 2001; 12(1):69-78. PubMed ID: 11236066
[TBL] [Abstract][Full Text] [Related]
34. Challenges and Advances in Gene Therapy Approaches for Neurodegenerative Disorders.
Donde A; Wong PC; Chen LL
Curr Gene Ther; 2017; 17(3):187-193. PubMed ID: 29034834
[TBL] [Abstract][Full Text] [Related]
35. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
36. Viral vectors in the treatment of Parkinson's disease.
Latchman DS; Coffin RS
Mov Disord; 2000 Jan; 15(1):9-17. PubMed ID: 10634236
[TBL] [Abstract][Full Text] [Related]
37. Neurotrophins and neurodegeneration.
Dawbarn D; Allen SJ
Neuropathol Appl Neurobiol; 2003 Jun; 29(3):211-30. PubMed ID: 12787319
[TBL] [Abstract][Full Text] [Related]
38. Gene transfer to the brain: emerging therapeutic strategy in psychiatry?
Lesch KP
Biol Psychiatry; 1999 Feb; 45(3):247-53. PubMed ID: 10023497
[TBL] [Abstract][Full Text] [Related]
39. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
40. Gene Therapy in the Management of Parkinson's Disease: Potential of GDNF as a Promising Therapeutic Strategy.
Behl T; Kaur I; Kumar A; Mehta V; Zengin G; Arora S
Curr Gene Ther; 2020; 20(3):207-222. PubMed ID: 32811394
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
